Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnostic tests for HPV infection.

Peter V Chin-Hong1, Jeffrey D Klausner

  • 1Department of Medicine, University of California in San Francisco, USA.

MLO: Medical Laboratory Observer
|November 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Lower Socioeconomic Status and SARS-CoV-2 Positivity in Los Angeles, California.

Journal of preventive medicine and public health = Yebang Uihakhoe chi·2021
Same author

Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions.

Drugs·2021
Same author

Heterogeneity in SARS-CoV-2 Positivity by Ethnicity in Los Angeles.

Journal of racial and ethnic health disparities·2021
Same author

Acceptability and feasibility of screening pregnant women for sexually transmitted infections in Rawalpindi, Pakistan.

International journal of STD & AIDS·2021
Same author

Using Machine Learning to Predict Young People's Internet Health and Social Service Information Seeking.

Prevention science : the official journal of the Society for Prevention Research·2021
Same author

Reply: Seroprevalence of SARS-CoV-2 After the Largest Initial Epidemic Wave in the United States: Findings from New York City, May 13-July 21, 2020.

The Journal of infectious diseases·2021

Human papillomavirus (HPV) infection is common and linked to cervical cancer. HPV testing, using methods like the hybrid capture assay, offers higher sensitivity than Pap tests and is increasingly used for screening.

Area of Science:

  • Oncology
  • Virology
  • Infectious Diseases

Background:

  • Human papillomavirus (HPV) is a prevalent sexually transmitted infection.
  • HPV-associated neoplasms, particularly cervical cancer, contribute significantly to global morbidity and mortality.
  • Advances in molecular biology have led to improved HPV detection methods.

Purpose of the Study:

  • To highlight the role of HPV testing in cervical cancer screening.
  • To discuss the FDA-cleared hybrid capture second-generation assay for HPV detection.
  • To explore the integration of HPV testing into cervical cancer screening algorithms.

Main Methods:

  • Utilizing the hybrid capture second-generation assay with RNA probes for high-risk and low-risk HPV types.
  • Comparing the sensitivity of HPV testing with the traditional Pap test.

Related Experiment Videos

  • Incorporating HPV testing into cervical cancer screening protocols.

    • Main Results:

    • The hybrid capture second-generation assay is the sole FDA-cleared test for cervical HPV detection.
    • HPV testing demonstrates higher sensitivity compared to the Pap test for cervical cancer screening.
    • HPV testing is being integrated into cervical cancer screening algorithms due to its sensitivity.

    Conclusions:

    • HPV testing is becoming a crucial component of cervical cancer screening due to its superior sensitivity.
    • The development of HPV therapies and vaccines necessitates systematic HPV testing to identify eligible populations.
    • Continued advancements in HPV testing methods will further enhance cervical cancer prevention strategies.